Alison Fox‐Robichaud

Prognostic utility and characterization of cell-free DNA in patients with severe sepsis

Dhruva J. Dwivedi, Lisa J. Toltl, Laura L. Swystun et al. · Critical Care · 2012 · 313 citations · Full text

Veterinary Medicine, Clinical Sciences, Critical Care Medicine +16

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Philippe Bégin, Jeannie Callum, Erin Jamula et al. · Nature Medicine · 2021 · 275 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial

François Lamontagne, Maureen O. Meade, Paul C. Hébert et al. · Intensive Care Medicine · 2016 · 247 citations

Medicine, Perioperative Medicine, Pharmacotherapy +15

Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis*

Daniel Ricciuto, Claúdia C. dos Santos, Michael Hawkes et al. · Critical Care Medicine · 2011 · 238 citations

Veterinary Medicine, Internal Medicine, Acute Care Medicine +16

Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds.

Alison Fox‐Robichaud, Derrice Payne, Shabih U. Hasan et al. · Journal of Clinical Investigation · 1998 · 235 citations · Full text

Veterinary Medicine, Pharmacotherapy, Bioavailability +16